BTIG Initiates Quoin Pharmaceuticals Coverage With Buy Rating, $14 Target
BTIG initiated coverage with a Buy rating and a $14 price target. The target implies 211.1% upside from the Oct. 9 close of $4.50.
BTIG initiated coverage with a Buy rating and a $14 price target. The target implies 211.1% upside from the Oct. 9 close of $4.50.